MediPharm Labs has completed their first shipment to France.
The French medicinal cannabis market is projected to experience significant growth over the coming years. Conservative estimates place the market at US$187.6 million by 2025, rising to US$213.3 million by 2030 under current regulatory conditions.(1)
"MediPharm's completion of our first production order and subsequent shipment to France marks our entry into one of Europe's most promising emerging medical cannabis markets," said David Pidduck, CEO of MediPharm Labs. "This achievement underscores our ability to establish new pathways to market and deliver pharmaceutical-grade products that meet stringent European standards."
For more information:
MediPharm Labs
medipharmlabs.com
